Across the United States, religious institutions are finding themselves at the center of a worsening public health crisis driven by the emergence of xylazine, commonly referred to as 'tranq.' Originally intended as a veterinary sedative, the drug is increasingly being detected in the illicit opioid supply, often combined with fentanyl. Because xylazine is not an opioid, standard overdose reversal medications like naloxone are ineffective at reversing its specific sedative effects, creating new challenges for community outreach programs and emergency responders.

Churches are adapting their traditional roles to provide harm reduction services, including the distribution of supplies and offering safe spaces for those struggling with substance use disorders. While the BBC reports that these institutions are filling a critical gap in the social safety net, the broader landscape of the crisis remains complex. Health experts note that the combination of fentanyl and xylazine leads to higher rates of severe skin ulcers and prolonged sedation, which complicates the ability of outreach workers to provide immediate medical assistance. The involvement of churches highlights a shift in how local communities are attempting to mitigate the impact of synthetic opioids, moving beyond traditional law enforcement approaches to prioritize direct, on-the-ground support for affected individuals.